| 000 | 01583 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516061820.0 | ||
| 264 | 0 | _c20111219 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1474-1768 | ||
| 024 | 7 |
_a10.1038/nrc3151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerndt, Norbert | |
| 245 | 0 | 0 |
_aTargeting protein prenylation for cancer therapy. _h[electronic resource] |
| 260 |
_bNature reviews. Cancer _c10 2011 |
||
| 300 |
_a775-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAlkyl and Aryl Transferases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFarnesyltranstransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMonomeric GTP-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeuropeptides _xmetabolism |
| 650 | 0 | 4 |
_aProtein Prenylation _xdrug effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRas Homolog Enriched in Brain Protein |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aHamilton, Andrew D | |
| 700 | 1 | _aSebti, Saïd M | |
| 773 | 0 |
_tNature reviews. Cancer _gvol. 11 _gno. 11 _gp. 775-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrc3151 _zAvailable from publisher's website |
| 999 |
_c21251867 _d21251867 |
||